Krishna Vaddi Buys 100,000 Shares of Prelude Therapeutics Incorporated (NASDAQ:PRLD) Stock
Prelude Therapeutics Incorporated (NASDAQ:PRLD – Get Free Report) CEO Krishna Vaddi acquired 100,000 shares of...
Your Source for Insightful Trends and Discussions.
Prelude Therapeutics Incorporated (NASDAQ:PRLD – Get Free Report) CEO Krishna Vaddi acquired 100,000 shares of...